Plain-English translation of NCT04039503 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 diabetes research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial studied whether , a new injectable medication, could help people with type 2 diabetes control their blood sugar better when added to their existing insulin treatment. About 475 people participated and received either the medication or a placebo injection once a week for nearly a year. The study compared three different doses of the medication to see which worked best and was safest.
Many people with type 2 diabetes struggle to control their blood sugar even when taking insulin. This medication was being tested to see if it could fill that gap by working alongside insulin to bring blood sugar levels into a healthier range.
Participants attended about 23 visits over roughly 47 weeks and received either the medication or placebo as a weekly injection under the skin, which they could give themselves at home. They continued taking their regular insulin and metformin as before. The study checked their blood sugar levels, weight, and overall health throughout the trial to compare how well the medication worked compared to placebo.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States